Quick Answer
Mass tort lawsuit funding is a cash advance for a plaintiff whose individual injury claim is part of a mass tort or MDL. Each plaintiff’s case is reviewed on its own, so the advance depends on that person’s injuries and evidence. Class action funding works differently, since members usually share a formula-based payout.
Mass tort lawsuit funding is repaid only from the plaintiff’s settlement, and it is usually non-recourse. Funders look at the injury, proof of product use, bellwether results, and how far along the litigation is. Because these cases often take three to seven years or more, funding can help cover living costs during the long wait.
Many people use the terms mass tort and class action as if they mean the same thing. For anyone thinking about funding, the two work very differently.
These large cases are also more common than most people realize. As of June 2026, federal courts were handling 159 MDL dockets with more than 202,000 pending actions. The single largest docket, which involves talcum powder products, had over 68,000 cases on its own.
With so many people waiting on the same litigation, mass tort lawsuit funding has become an important option for plaintiffs facing years of bills before any settlement arrives.
This guide walks through the difference between mass torts and class actions, how MDLs work, and how funding is handled for each. It also covers common mass tort cases, why they take so long, and how to qualify.
Mass Tort vs. Class Action and Why the Difference Matters for Funding
In a mass tort, many people are harmed by the same product or event, but each person keeps an individual claim. Each plaintiff has their own attorney, their own injuries, and their own case value.
In a class action, one or a few people represent a large group with similar claims. The group usually shares one settlement, and each member receives a portion based on a set formula.
This difference shapes how funding works. Mass tort lawsuit funding looks at each plaintiff’s injuries and evidence. Class action funding depends on the expected share of a group payout, which is often smaller and harder to predict.
The table below shows the main differences side by side.
| Factor | Mass tort | Class action |
|---|---|---|
| Type of claim | Individual claim for each plaintiff | One group claim led by class representatives |
| Attorney | Each plaintiff usually has their own | Class counsel represents the whole group |
| Settlement value | Based on each person’s injuries | Split among members by formula |
| Funding review | Each case reviewed on its own | Based on the expected individual share |
| Typical injuries | Serious personal injuries | Often smaller financial or consumer losses |
What Is Multidistrict Litigation (MDL)?
Multidistrict litigation, or MDL, is a federal process that groups similar cases from across the country in front of one judge. The goal is to handle shared steps, such as evidence gathering and expert reports, in one place. For plaintiffs, this setup is what makes mass tort lawsuit funding possible on a case-by-case basis.
Each case inside an MDL stays separate. If a case doesn’t settle during the MDL, it can be sent back to its original court for trial.
Most mass tort lawsuit funding involves cases in an MDL. It works like any pre-settlement cash advance, with repayment coming from the settlement. A plaintiff in one of these dockets may also hear the term MDL lawsuit cash advance, which describes the same type of funding.
How Mass Tort Lawsuit Funding Works
Mass tort lawsuit funding follows the same basic idea as other injury funding. A plaintiff receives part of the expected settlement now and repays it when the case pays out. If the case is lost, the plaintiff typically owes nothing.
The review process looks a little different, though. Here is how it usually works.
- The plaintiff applies and shares their attorney’s contact details.
- The funder confirms the claim is filed or registered in the litigation.
- The attorney sends proof of product use or exposure, plus medical records.
- The funder reviews the injury, the stage of the litigation, and any bellwether results.
- If approved, the plaintiff signs an agreement and receives the funds.
Individual Case Valuation Within an MDL
Even though thousands of cases share one MDL, each claim has its own value. A plaintiff with a serious injury, clear proof of product use, and strong medical records may qualify for a larger mass tort lawsuit funding offer than someone with milder symptoms.
Funders also keep advances to a small share of the expected payout. Knowing how much funding a case can support helps plaintiffs set realistic expectations for mass tort settlement funding.
Bellwether Trials and Their Role in Funding Decisions
Bellwether trials are early test trials chosen from cases in an MDL. Judges use these bellwether trials to see how juries respond to the evidence.
For funders, these results matter a lot. Strong plaintiff verdicts often raise expected settlement values, which can lead to larger mass tort lawsuit funding offers. Weak results can make funders more cautious.
Take a plaintiff named Rachel, who joined a hernia mesh MDL. Early on, her mass tort lawsuit funding offer was modest. After two bellwether verdicts went in favor of plaintiffs, she qualified for a larger advance.
How Class Action Funding Works Differently
Class action funding is less common than mass tort lawsuit funding because each member’s share is often small and unknown until the case ends. Many class actions involve consumer or financial losses worth a few hundred dollars per person.
Funding is more likely when the class action involves real injuries or larger individual shares. Some providers of pre-settlement funding review class action claims case by case.
Formula-Based Distribution
Class action settlements are paid through a formula approved by the court. A claims administrator reviews each member’s claim and assigns a payout based on set factors.
Once a settlement is approved and the individual share is clear, a class action settlement advance becomes easier to arrange. Before then, the uncertainty makes many funders hesitant.
Common Types of Mass Tort Cases (Drugs, Devices, Environmental)
Mass torts usually involve products or events that harm large numbers of people in similar ways. Here are the most common categories.
- Dangerous drugs that cause serious side effects not listed on the label.
- Defective medical devices, such as hernia mesh or hip implants.
- Consumer products linked to illness, such as talcum powder.
- Environmental exposure, such as firefighting foam or contaminated water.
- Toxic chemicals used in homes, farms, or workplaces.
Some of the largest federal dockets today involve talcum powder, hernia mesh, and firefighting foam. Mass tort pre-settlement funding is available in many of these cases once the claim is filed and the injury is documented. Mass tort lawsuit funding offers in these dockets often reflect how far the litigation has moved.
Why Mass Tort Cases Take So Long (3-7+ Years)
Mass torts often take far longer than a typical personal injury settlement. Many last three to seven years, and some run even longer.
Here are a few reasons for the long timeline.
- Discovery involves millions of pages of company records.
- Expert witnesses must study complex medical and scientific questions.
- Bellwether trials take years to schedule and complete.
- Settlement talks cover thousands of claims at once.
- After a global settlement, each claim still has to be reviewed and paid.
This long wait is the main reason mass tort lawsuit funding exists. Bills keep coming, even when a case is moving slowly through a busy federal docket.
How to Qualify for Mass Tort or Class Action Funding
The basic rules for mass tort pre-settlement funding are similar to other injury funding, with a few extra steps. Here is what most funders look for when deciding whether a plaintiff can qualify for funding in a mass tort.
- An attorney who represents the plaintiff in the litigation.
- A claim that has been filed or registered in the MDL or mass tort.
- Proof of product use or exposure, such as pharmacy or surgical records.
- A medical diagnosis that matches the injuries in the litigation.
- For class actions, an approved settlement and a clear individual share.
Credit scores and income usually don’t matter. Mass tort lawsuit funding is repaid from the settlement, so the strength of the claim is what counts. Plaintiffs who meet these points often find mass tort lawsuit funding easier to get than they expected.
Final Takeaway: How Mass Tort Lawsuit Funding Works
Mass tort lawsuit funding gives plaintiffs access to part of their expected settlement during litigation that can last many years. Each claim is reviewed on its own, and bellwether results often shape how much a funder will offer.